SYMDEKO is a drug for the treatment of cystic fibrosis (CF) in patients 12 years and older, who have specific gene mutations. CF is a serious genetic disorder that results in the formation of thick mucus that builds up in the lungs and other parts of the body. This can lead to severe breathing problems.
SYMDEKO is packaged as two tablets. One tablet, a combination of two drugs (tezacaftor and ivacaftor) is taken by mouth in the morning. The second tablet (ivacaftor) is taken by mouth, in the evening.